Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

GLP-1 agonists may increase the risk of hair loss.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

Metformin may improve acanthosis nigricans by reducing insulin resistance.

Linagliptin slows down premature aging in certain mice.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

The β-sitosterol hair gel is effective and promising for treating hair loss.

Tirzepatide may improve hair loss by reducing insulin resistance.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Higher alarin levels might link hair loss and metabolic syndrome.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib shows promise for treating alopecia areata with mild side effects.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

Herbal formula shows promise for hair loss treatment.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

A new treatment for hair loss shows promise with fewer side effects.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.